AVTX
AVTX
NASDAQ · Biotechnology

Avalo Therapeutics Inc

$14.19
+1.04 (+7.91%)
As of Feb 8, 2:01 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +131.9% upside
Low Target $27.78
Average Target $32.91
High Target $47.11
Current Price $14.19
Current
$14.19
Target
$32.91
$27.78 $32.91 avg $47.11
Scenario Analysis
Bear Case
$27.78
95.8%
Low target
Base Case
$32.91
+131.9%
Avg target
Bull Case
$47.11
+232.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$36.58
-61.2% from high
52-Week Low
$16.46
+-13.8% from low
Target vs 52W High
$32.91
-10.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%